MINNEAPOLIS and BEIJING, Aug. 26, 2015 /PRNewswire/ -- ECM Medical (ECM), a China-focused medical device company, announces the acquisition of Greater China distribution rights for the Interfuse™ System of novel spinal implants developed and manufactured by Vertebral Technologies, Inc (VTI).
VTI's breakthrough lumbar interbody fusion system is based on proprietary modular technology. The InterFuse™ System is designed to enable spine surgeons to achieve the predictable efficacy of a large, biomechanically stable footprint, while utilizing familiar, less invasive approaches.
Surgeons are able to optimize conditions for successful lumbar fusion using VTI's intra-operative assembly™ technology to create an ALIF-sized footprint but with delivery through a smaller access channel than with currently available fusion products.
"While our products have approval in 38 markets worldwide, China is a key market, said Matt Kyle, CEO, VTI. "We are excited that our technologies will be available to surgeons and patients in China."
The initial Greater China launch will take place in Hong Kong and Macau in the fourth quarter of 2015 and in mainland China after regulatory approvals.
"Orthopedic implants are a key area in our product portfolio and the Interfuse™ System offers unique benefits over other fusion products," said Brian Hakim, US Vice President, ECM Medical. "ECM is pleased to be partnering with VTI to bring a next generation fusion implant to the China market."
About VTI
Vertebral Technologies, Inc. is a privately held company based in Minnetonka, MN, USA. It is dedicated to the design, development, manufacturing and marketing of medical devices to address painful conditions of the spine through less-invasive surgical approaches.
For more information about VTI, visit http://www.vti-spine.com
About ECM Medical
ECM Medical is an international medical device company based in China and the US. ECM Medical partners with western medical device firms to bring the best products to the Chinese market and works to ensure the products have the best access to the Chinamarket. ECM Medical licenses products approved in their home countries and then performs and funds the steps necessary to achieve China FDA approval before marketing and selling those products across China.
For more information about ECM Medical, visit http://www.ecmmedical.com
MEDIA CONTACT INFORMATION
Jonathan Hakim
ECM Medical
T: +86 (10) 5288 7308
Email
MEDIA CONTACT INFORMATION
Matthew Kyle
Vertebral Technologies, Inc.
T: +1 952 912 5400
Email